Amy Lee – Medium

Amy Lee

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) Secures Strong Buy Rating as MAVERIC Trials Expand

On October 24, 2024, H.C. Wainwright & Co. maintained its Buy rating for Cardiol Therapeutics with a $9 price target, driven by the…

Apr 10

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) Secures Strong Buy Rating as MAVERIC Trials Expand

Apr 10

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) Gains Momentum as H.C.

H.C. Wainwright has reaffirmed its “Buy” rating and a $9.00 price target for Cardiol Therapeutics (NASDAQ: CRDL), following the company’s…

Apr 10

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) Gains Momentum as H.C.

Apr 10

Inflammation plays a pivotal role in the progression of heart failure.

📊 Scientific Advantages of CRD-38: 🩺 Reduces inflammatory responses that contribute to heart failure progression 🩺 Subcutaneous…

Apr 10

Inflammation plays a pivotal role in the progression of heart failure.

Apr 10

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) Drives Late-Stage Development of CardiolRx™ for…

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage biotech company focused on advancing CardiolRx™, a purified oral…

Apr 1

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) Drives Late-Stage Development of CardiolRx™ for…

Apr 1

Inside Cardiol Therapeutics Inc.

Cardiol Therapeutics is pioneering the integration of cannabinoid science and cardiovascular medicine to develop targeted therapies for…

Apr 1

Inside Cardiol Therapeutics Inc.

Apr 1

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) CEO David Elsley Discusses CardiolRx™ and Phase III…

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) continues to strengthen its position as a leader in cardiovascular drug development with…

Apr 1

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) CEO David Elsley Discusses CardiolRx™ and Phase III…

Apr 1

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL): Where Clinical Research Meets Compassionate Care

Cardiol Therapeutics is at the intersection of science, innovation, and humanity. On its Insights page, the company outlines how…

Mar 24

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL): Where Clinical Research Meets Compassionate Care

Mar 24

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL): Pioneering Breakthroughs in Inflammatory Heart…

Cardiol Therapeutics is leading a new era in cardiovascular medicine, targeting the inflammasome — a critical driver of inflammation and…

Mar 24

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL): Pioneering Breakthroughs in Inflammatory Heart…

Mar 24

Cardiol Therapeutics (NASDAQ: CRDL): Targeting the Root of Heart Disease with Cannabidiol-Based…

Cardiol Therapeutics is a biotech company with a clear vision: to tackle cardiovascular disease by treating what causes it — not just what…

Mar 24

Cardiol Therapeutics (NASDAQ: CRDL): Targeting the Root of Heart Disease with Cannabidiol-Based…

Mar 24

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL): A New Era in Cardiovascular Treatment

Cardiol Therapeutics is pioneering cutting-edge therapies to combat cardiovascular disease, with a focus on improving patient outcomes for…

Mar 19

Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL): A New Era in Cardiovascular Treatment

Mar 19

Amy Lee

Amy Lee

Research Analyst exploring the world of insights and innovation. Sharing ideas and stories while cherishing moments with family

Following

Help

Status

About

Careers

Press

Blog

Privacy

Rules

Terms

Text to speech